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the CC BY-NC-ND license (http://creaAbstract Objective: To investigate the urodynamic study (UDS) patterns, obstruction status,
continence status, and their correlations among neurologically intact women with lower uri-
nary tract symptoms (LUTS) through an epidemiological and logistic regression analyses.
Methods: We retrospectively analyzed the UDS data of 3265 neurologically intact women with
LUTS (2002e2014). Five UDS patterns were identified: normo-active detrusor/sphincter (NA, or
DSI, detrusor/sphincter intact), idiopathic detrusor overactivity (IDO), idiopathic sphincter
overactivity (ISO), IDO þ ISO, and detrusor underactivity (DUA). Analyses of UDS pattern distri-
bution and stratification were performed (based on a modification of the European Urological
Association-Madersbacher classification system), and their correlations with bladder outlet
obstruction (BOO) and stress urinary incontinence (SUI) status were evaluated via logistic
regression analysis.
Results: NA, IDO, IDO þ ISO, ISO, and DUA were noted in 927 (28.4%), 678 (20.8%), 320 (9.8%),
689 (21.1%), and 651 (19.9%) cases, respectively. Moreover, storage, storage þ voiding, and
voiding symptoms were noted in 62.4%, 21.1%, and 16.5% cases, respectively, whereas BOO
and SUI were observed in 12.1% and 29.0% cases, respectively. The risk factors for BOO
included NA, IDO, ISO, and IDO þ ISO, whereas the protective factors against BOO included
storage symptoms, SUI, storage þ voiding symptoms, and complaint duration within 1e12
months. NA was the only risk factor for SUI, whereas BOO, storage þ voiding symptoms,
IDO, and storage symptoms were protective factors for SUI.(C. Qu), yin202@163.com (L. Yin).
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UDS and LUTS in women with non-neurogenic bladder 11Conclusion: Five UDS patterns were identified among neurologically intact women with LUTS.
Functional abnormalities of the detrusor and/or sphincter were the main causes of LUTS, and
were correlated with the BOO or SUI status. Thus, the UDS pattern can provide additional in-
formation regarding the risk factors for BOO or SUI status, as compared to symptomatic typing.
ª 2016 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
A prior epidemiological study of lower urinary tract symp-
toms (LUTS) among 18,992 respondents in China indicated
that 55.5% of adult women experienced LUTS, and that
nocturia, urgency, and stress urinary incontinence (SUI)
were the more prevalent conditions [1]. Moreover, LUTS
negatively affects the mental well-being of female pa-
tients, and its prevalence is known to increase with age; in
fact, it has been found to affect up to 55% of elderly in-
dividuals in France, Germany, the UK, and the USA [2].
Neurologically intact male or female patients with LUTS
may suffer from various urodynamic disorders or a combi-
nation of them, including normo-active detrusor/sphincter
(NA), idiopathic detrusor overactivity (IDO), idiopathic
sphincter overactivity (ISO), IDO þ ISO, or detrusor under-
activity (DUA) [3e5]. In patients with disorders such as
bladder outlet obstruction (BOO), SUI, and overactive
bladder (OAB), LUTS can be further stratified into the
following three categories: storage, voiding, and post-
micturition symptoms. However, a secondary analysis of
data from the EPIC study (a multinational population-based
survey of 19,165 adults) indicated a marked overlap of
storage, voiding, and postmicturition symptoms among men
in general (n Z 7210) and among men with OAB symptoms
(nZ 502); furthermore, men with OAB were more likely to
experience multiple LUTS subtypes [6]. Among the men
with OAB symptoms (nZ 502), 29.3% exhibited only storage
symptoms (probably closely related to IDO), whereas the
others exhibited voiding and/or postmicturition symptoms
alone or in combination with storage symptoms [6]. How-
ever, symptomatic evaluation alone is not very efficient for
determining the treatment for LUTS. Hence, elucidation of
the intrinsic nature of detrusor and/or sphincter dysfunc-
tion is vital.
These findings suggest that a comprehensive urologic
assessment of male patients is needed, and such analysis
should also be performed in female patients. In our center,
comprehensive urodynamic study (UDS) is routinely per-
formed in patients with LUTS who are unresponsive to
medical treatment or in patients with more complex com-
plaints. Moreover, a previous retrospective study developed
a classification system for UDS patterns for elderly male
patients with non-neurogenic LUTS, which can be used as a
reference guideline for diagnosis and treatment [7].
In the present study, we focused on such UDS analyses
among adult female patients with LUTS. Through the
analysis of individualized UDS data, we aimed to obtain
comprehensive information regarding the general and
stratified distribution as well as the prevalence of variousUDS patterns and their correlation with BOO or SUI status
among neurologically intact adult female patients with
LUTS by using the current International Continence Society
(ICS) definitions [8].
Furthermore, urethral sphincter pseudodyssynergia or
poor relaxation of the urethral sphincter, which is actually
a surrogate symptom of non-neurogenic lower urinary tract
dysfunction (LUTD) and is represented by ISO in the present
study, can be identified using anal sphincter electromyog-
raphy (EMG) [4,5]. The functional status of the detrusor and
sphincter (either overactive, normo-active, or underactive)
can be classified according to the European Urological As-
sociation (EUA)eMadersbacher classification system for
neurogenic LUTD [4], and such functional disorders may
develop in either neurologically intact adult male or female
patients [5,7,9,10]. In the present study, we aimed to
establish a modified version of the urodynamic pattern
classification system for non-neurogenic LUTD based on this
Madersbacher classification system for neurogenic LUTD.
2. Patients and methods
2.1. Creation of a urodynamic pattern classification
system for non-neurogenic LUTS
Considering the absence of sphincter underactivity (SUA) in
several guidelines, we established a UDS pattern classifi-
cation system for patients with non-neurogenic LUTS,
which was based on a modified version of the EUA-
Madersbacher classification system [4] (Fig. 1). In addition
to the omission of three subtypes of SUA, we included
detrusor/sphincter intact as a subtype of NA.
2.2. Subjects and criteria
We examined a total of 3265 women with LUTS from May
2002 to November 2014 who presented to the out-patient
clinic or were hospitalized; of these, 2085 directly visited
the hospital from the community and 1180 we referred by
tertiary centers. All the patients were of Chinese ethnicity,
except for five Caucasian patients from Russia and
Kazakhstan. Patients with occult or overt neuropathy
(multiple sclerosis, multiple system atrophy, dementia,
Parkinson’s disease, diabetes mellitus, cerebrovascular
disorder, spinal cord injury, and other conditions), heavy
pelvic organ prolapse, previous transurethral or pelvic
surgery, and active urinary tract infection were excluded.
Symptoms were stratified as storage symptoms,
storage þ voiding symptoms, and voiding symptoms;
Figure 1 Classification system of urodynamic patterns in neurogenic or non-neurogenic lower urinary tract dysfunction. (A)
European Urological Association (EUA)-Madersbacher classification system of neurogenic lower urinary tract dysfunction. (B)
Classification system for urodynamic patterns in patients with non-neurogenic LUTS based on a modified version of the EUA-
Madersbacher classification system.
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voiding symptoms. Storage symptoms included increased
micturition frequency, nocturia, urinary urgency, and uri-
nary incontinence; voiding symptoms included slow or weak
stream, hesitancy, and terminal dribble; and post-
micturition symptoms included the sensation of incomplete
emptying and postmicturition dribble [8]. In addition to
symptomatic stratification, female patients with LUTS were
further stratified according to the extent of BOO (absence
of BOO, mild BOO, and typical BOO), the extent of SUI (SUI
and absence of SUI), age (18e39, 40e59, 60e79, or 80e97
years), and their first test date (2002e2006, 2007e2010,
and 2011e2014). The duration of their complaint (range
1e480 months) was subdivided into four quartiles (1e12,
12e36, 36e72, and 72e480 months), and was used as an
independent variable in subsequent logistic regression
analysis.
Patients with NA, IDO, IDO þ ISO, and ISO were treated
with anti-muscarinic agents, a adrenergic antagonist, or
baclofen (GABA-ergic [g-aminobutyric acid]-agonist),
respectively [7]. Moreover, patients with DUA underwent
a treatment regimen involving continuous indwelling cath-
eterization without clamping of the draining tube, pyrido-
stigmine bromide, baclofen, a-adrenergic antagonist, and
decoctions of Chinese medicinal herbs, for 4e6 weeks [7].
Furthermore, transurethral incision of the bladder neck or
sacral neuromodulation (InterStim therapy) could be
attempted in patients who were unresponsive to the
abovementioned treatments [11e13]. The results of the
treatment were monitored and carefully assessed.
2.3. Urodynamic study program
The UDS (Urovision Janus, Life Tech, USA; Solar, MMS, the
Netherlands; and Andromeda, Germany) included
maximum flow rate (free Qmax) assessment, filling cys-
tometrography (CMG), voiding pressure-flow study (PFS),
anal sphincter EMG, and urethral pressure profilometry(UPP) according to previously described techniques
[5,9,14]. The methods, definitions, and units used were
based on the standards recommended by the ICS, except
where specifically noted [8]. CMG and PFS were performed
by using an 8F dual lumen catheter (Xubu Medical Appliance
Company, Dantu, Jiangsu, China), with the infusion of
normal saline at a rate of 50 mL/min, after which bladder
pressure (Pves) was recorded. Intra-abdominal pressure
(Pabd) was recorded by using a 12F transrectal balloon
catheter (Cook Urological Incorporated, IN, USA). Anal
sphincter EMG was simultaneously recorded by two needle-
guided-wire electrodes placed at the 3 and 9 o’clock posi-
tions to the anus [5]. After catheterization, the postvoid
residual urine was evacuated and measured. Thereafter,
CMG and PFS were completed with the patients sitting or
squatting on a commode, with the uroflowmeter placed
below, to collect the voided liquid. The maximum flow rate
(Qmax) and detrusor pressure (Pdet Z PvesPabd) were
consecutively measured by asking the patient to void.
Involuntary phasic or terminal detrusor overactivity was
considered to indicate the presence of IDO [8]. After the
end of the UPP, the maximum urethral closure pressure and
the functional profile length were recorded. The qualifi-
cation and quantification of BOO were performed based on
the female BOO standards of the Blaivas nomogram [15],
whereas the ICS nomogram and Schaefer nomogram were
also occasionally used.
2.4. Definition of female UDS patterns
NA was diagnosed based on the absence of a urodynamically
visible detrusor and/or sphincter dysfunction during UDS.
Theoretically, NA also includes certain types of bladder
oversensitivity, such as type 1 OAB [16] or a condition that
was previously described as sensory urgency [8,17]. IDO was
diagnosed based on the presence of urodynamically visible
detrusor overactivity during UDS (either phasic or termi-
nal). IDO includes type 2, 3 and 4 OAB, or the condition
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sented the simultaneous occurrence of IDO and ISO. A
diagnosis of ISO was confirmed based on the presence of
increased external sphincter activity during voluntary
voiding, as indicated by increased sphincter activity with a
sustained detrusor contraction during PFS or simply by a
minus tense/loose (TL) value [9]. DUA is defined as a
contraction of reduced strength and/or duration that re-
sults in prolonged bladder emptying and/or a failure to
achieve complete bladder emptying within a normal time
span [8].2.5. Study design
The study was approved by the local ethics committee, and
all participants provided written informed consent. Our
diagnosis and treatment program was first based on
whether the detrusor was severed or intact, followed by
the type of UDS pattern if a satisfactory PFS result was
available, and then according to the five UDS patterns,
particularly DUA, regardless of whether PFS results wereFigure 2 Study design, flow diagram, outcome, and treatment t
with LUTS. BPS/IC, bladder pain syndrome/interstitial cystitis; DUA
ISO, idiopathic sphincter overactivity; NA, normo-active detrusor/
LUTS, lower urinary tract symptoms; UDS, urodynamic study.available. The program has been mapped as a flowchart in
Fig. 2.
2.6. Statistical analysis
SPSS version 17.0 (SPSS, Chicago, IL, USA) for Windows was
used for statistical analysis. For all analyses, the variables
are presented as patient number and percentage of the
entire cohort. Categorical data were analyzed using the
Chi-square test with Fisher’s exact probability test as
appropriate, and each UDS pattern was compared with the
other four patterns overall [18]. A p value of <0.05 was
considered statistically significant.
The likelihood of clinical progression to BOO or SUI was
evaluated with the other clinical and UDS variables. In the
binary logistic regression analysis, the formula was as
follows:
YðBOO or SUIÞZb0 þ b1X1 þ b2X2 þ b3X3 þ b4X4 þ b5X5 þ b6X6
Either BOO or SUI was used as the dependent variable
(Y1 and Y2). b0 remained constant in each formula. Therends of neurologically intact female patients aged >18 years
, detrusor underactivity; IDO, idiopathic detrusor overactivity;
sphincter; TURN, transurethral resection of the bladder neck;
Table 1 UDS pattern distribution of adult female patients neurologically intact with LUTS from 2002 to 2014. (n Z 3265).
Stratification of clinical variables Total, n (%) UDS pattern, n (%)
NA 927 (28.4) IDO 678 (20.8) IDO þ ISO 320 (9.8) ISO 689 (21.1) DUA 651 (19.9)
Symptomatic
Storage symptoms 2104 (64.5) 680 (20.8) 507 (15.6) 185 (5.7) 467 (14.3) 265 (8.1)
Storage þ voiding symptoms 635 (19.4) 130 (4.0) 124 (3.8) 99 (3.0) 145 (4.4) 137 (4.2)
Voiding symptoms 526 (16.1) 117 (3.6) 47 (1.4) 36 (1.1) 77 (2.4) 249 (7.6)
pa 0.001 0.001 0.001 0.001 0.001
BOO
Absence of BOO 2869 (87.9) 756 (23.2) 598 (18.3) 282 (8.7) 608 (18.6) 625 (19.1)
Slight BOO 344 (10.5) 135 (4.1) 74 (2.4) 37 (1.1) 75 (2.3) 23 (0.7)
Typical BOO 52 (1.6) 36 (1.1) 6 (0.1) 1 (0.0) 6 (0.2) 3 (0.1)
pa 0.001 0.244 0.135 0.226 0.001
SUI
Absence of SUI 2319 (71.0) 504 (15.4) 533 (16.3) 263 (8.1) 484 (14.8) 535 (16.3)
SUI 946 (29.0) 423 (13.0) 145 (4.5) 57 (1.7) 205 (6.3) 116 (3.6)
pa 0.001 0.001 0.001 0.612 0.001
Test date
2002e2006 944 (28.9) 319 (9.8) 207 (6.4) 81 (2.5) 139 (4.3) 198 (6.1)
2007e2010 994 (30.5) 234 (7.2) 183 (5.6) 128 (3.9) 258 (7.9) 191 (5.8)
2011e2014 1327 (40.6) 374 (11.4) 288 (8.8) 111 (3.4) 292 (8.9) 262 (8.0)
pa 0.001 0.089 0.001 0.001 0.609
Age at first consultation
18e39 598 (18.3) 152 (4.6) 133 (4.1) 68 (2.1) 137 (4.2) 108 (3.3)
40e59 1599 (49.0) 538 (16.5) 300 (9.2) 130 (4.0) 367 (11.3) 264 (8.0)
60e79 957 (29.3) 218 (6.7) 219 (6.7) 113 (3.4) 172 (5.2) 235 (7.2)
80e97 111 (3.4) 19 (0.6) 26 (0.8) 9 (0.3) 13 (0.4) 44 (1.4)
pa 0.001 0.051 0.001 0.001 0.001
a Inter-pattern Chi-square test; BOO, bladder outlet obstruction; NA, normo-active detrusor/sphincter; IDO, idiopathic detrusor
overactivity with sphincter synergia; ISO, idiopathic sphincter overactivity with detrusor normo-activity; IDO þ ISO, idiopathic detrusor
overactivity with idiopathic sphincter overactivity; DUA, detrusor underactivity with sphincter synergia or overactivity; LUTS, lower
urinary tract symptoms; SUI, stress urinary incontinence; UDS, urodynamic study.
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dummy variables: 18e39, 40e59, 60e79, and 80 years);
X2, test dates (3 dummy variables: 2002e2006, 2007e2010,
and 2011e2014); X3, complaint durations (4 dummy vari-
ables: 1e12 months, 12e36 months, 36e72 months, and
72e480 months); X4, symptomatic typing (3 dummy vari-
ables: storage symptoms, storage þ voiding symptoms, and
voiding symptoms); X5, UDS patterns (5 dummy variables:
NA, IDO, IDO þ ISO, ISO, and DUA); and X6, BOO (absence or
presence, when SUI was the dependent variable) or SUI
(absence or presence, when BOO was the dependent
variable).
3. Results
3.1. Distribution and stratification of UDS patterns
Among all the patients, NA, IDO, IDO þ ISO, ISO, and DUA
were observed in 927 (28.4%), 678 (20.8%), 320 (9.8%), 689
(21.1%), and 651 (19.9%), respectively (Table 1 and Fig. 3).
Moreover, with regard to symptom distribution, storage,
storage þ voiding, and voiding symptoms were noted in
64.5%, 19.4%, and 16.1% patients, respectively. In partic-
ular, BOO and SUI were observed in 12.1% and 29.0% pa-
tients, respectively.An inter-pattern Chi-square analysis indicated that pa-
tients with storage symptoms were more likely to have NA,
IDO, IDO þ ISO, and ISO as compared to those with voiding
symptoms or storage þ voiding symptoms (p Z 0.001),
whereas those with storage or voiding symptoms were more
likely to have DUA as compared to patients with
storage þ voiding symptoms (p Z 0.001). Patients who did
not have SUI were more likely to have NA, IDO, IDO þ ISO,
and DUA as compared to patients with SUI (p Z 0.001),
whereas the likelihood of ISO was comparable in patients
with and without SUI (p Z 0.612).
DUA is a general condition, and can be further sub-
divided into four subgroups according to sphincter function
and abdominal strain typednamely, DUA1 (DUA with
sphincter synergia), DUA2 (DUA with ISO and rectangular-
form abdominal strain), DUA3 (DUA with sphincter synergia
and gladiate-form strain), and DUA4 (DUA with ISO and
gladiate-form strain) (Fig. 3).
3.2. Clinical variables and their correlations
The meaningful results of binary logistic regression, such as
the b value (coefficient of regression), the Exp (b) (odds
ratio) and its 95% confidence interval are summarized in
Table 2. The risk factors for BOO (as Y1) included NA, IDO,
Figure 3 Urodynamic patterns of neurologically intact adult female patients with LUTS: (A) normo-active detrusor/sphincter, or
detrusor/sphincter intact (NA); (B) idiopathic detrusor overactivity with sphincter synergia (IDO); (C) idiopathic detrusor over-
activity with idiopathic sphincter overactivity (IDO þ ISO); (D) idiopathic sphincter overactivity with detrusor normo-activity (ISO);
(E) NA with BOO; (F) DUA with sphincter synergia (DUA1); (G) DUA with ISO and rectangular-form strain (DUA2); (H) DUA with
sphincter synergia and gladiate-form strain (DUA3); and (I) DUA with ISO and gladiate-form strain (DUA4). BOO, bladder outlet
obstruction; DUA, detrusor underactivity; UDS, urodynamic study.
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BOO included storage symptoms, SUI, storage þ voiding
symptoms, and complaint duration within 1e12 months.
Moreover, only NA was a risk factor for SUI (as Y2), whereas
BOO, storage þ voiding symptoms, IDO, and storage symp-
toms were protective factors against SUI (p Z 0.001).
3.3. Results of treatment for different UDS patterns
The primary therapy chosen for patients with different UDS
patterns depended on the UDS pattern; those with IDO, ISO,
IDO þ ISO, or even NA were treated with anti-muscarinic
agents, a-adrenergic antagonist, or baclofen (Fig. 2).
Approximately 65% of patients exhibited a good response to
their primary therapy; the regimen was changed in the
patients who had a poor response. Patients with pelvic pain
and poor treatment response were treated according to
guideline of bladder pain syndrome/interstitial cystitis
(BPS/IC) [19]. Finally, five refractory cases required sacral
neuromodulation therapy. Patients with both BOO or SUI
underwent transurethral resection of the bladder neck
(TURN) or sling procedure [9,20], whereas those with DUA
underwent a specific DUA regimen over 4e6 weeks. If noresponse to treatment was noted, sacral neuromodulation
or TURN was applied.
In 2004, 2009, and 2014, the DUA regimen was applied to
three cases with a large residual urine volume
(2500e2800 mL) that potentially had an iatrogenic origin,
and excellent results were achieved (Fig. 4). The ages of
these patients ranged from 33 to 61 years, and the
complaint duration was <1 month in all cases. Sphincter
synergia or relaxation during the voiding phase despite the
persistent absence of detrusor contraction was a predictive
factor of DUA, and was exhibited by one patient during the
first consultation (Fig. 4G) and by the other two patients
during the follow-up assessments (Fig. 4B, E).
4. Discussion
Based on the results of our epidemiological research, we
identified five UDS patterns among neurologically intact
adult female patients with LUTS. Although 28.4% of the
patients exhibited NA, nearly 70% of these patients had
detrusor and/or sphincter dysfunction. We believe that this
distribution should not be overlooked. Considering that
55.5% of adult women in China suffer from LUTS [1], the
Table 2 Independent variable risk and protective factors for or against BOO or SUI as dependent variables by binary logistic
regression analysis in adult female patients neurologically intact with LUTS from 2002 to 2014 (n Z 3265).
Risk or protective factors
as independent variables
b value SE Wald c2 Df Significance Exp (b) Exp (b) 95% CI
Lower limit Upper limit
Risk factors for BOO, b0 Z L1.911
NA 2.846 0.247 132.464 1 0.000 17.213 10.602 27.946
IDO 2.395 0.267 80.673 1 0.000 10.966 6.503 18.492
ISO 2.130 0.263 65.692 1 0.000 8.411 5.026 14.077
IDO þ ISO 1.536 0.290 28.004 1 0.000 4.646 2.630 8.025
Protective factors against BOO
Storage sym. 2.990 0.181 273.775 1 0.000 0.05 0.035 0.072
SUI 2.683 0.256 110.218 1 0.000 0.068 0.041 0.113
Storage þ voiding sym. 1.285 0.178 52.076 1 0.000 0.277 0.195 0.393
Complaint duration
(1e12 months)
0.474 0.180 6.948 1 0.008 0.622 0.438 0.886
Risk factors for SUI, b0 Z 0.193
NA 0.857 0.122 49.135 1 0.000 2.356 1.854 2.994
Protective factors against SUI
BOO 2.783 0.256 118.522 1 0.000 0.062 0.037 0.102
Storage þ voiding sym. 1.257 0.161 61.256 1 0.000 0.284 0.208 0.390
IDO 0.825 0.144 32.663 1 0.000 0.438 0.330 0.581
Storage sym. 0.702 0.130 29.045 1 0.000 0.495 0.384 0.640
95% CI, 95% confidence interval; BOO, bladder outlet obstruction; Df, degree of freedom; IDO, idiopathic detrusor overactivity; ISO,
idiopathic sphincter overactivity; LUTS, lower urinary tract symptoms; NA, normo-active detrusor/sphincter; SE, standard error; SUI,
stress urinary incontinence.
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dysfunction would be high. However, there were no sig-
nificant differences in the prevalence of IDO, IDO þ ISO, or
ISO between patients with mild or typical BOO and those
without BOO. Moreover, logistic regression analysis indi-
cated that these three patterns and NA were risk factors for
BOO. Hence, even though UDS is an optional test in patients
with LUTS in most Western countries, the pathological
conclusions underlying the UDS findings should not be
ignored. Logistic regression analysis is an important multi-
variable prediction model for determining individual prog-
nosis or diagnosis, and the results can indicate whether
further tests are needed, can be used to directly initiate
treatment, and can help reassure patients that their
symptoms may not likely have a serious cause [21].
According to an American Urological Association (AUA)-
commissioned survey, only 11% of urologists routinely per-
formed UDS when evaluating a “benign prostatic hyper-
plasia (BPH) patient” in 1995 [22]. In 2014, in a total of 3494
new BPH patients, the rate of application of UDS at the
initial BPH evaluation was only 5.4% [23]. Among female
patients with LUTS, Haylen et al. [24] noted that the rate of
UDS was also low, and hence, voiding difficulty may have
been overlooked as a diagnosis in comparison with urody-
namic SUI, OAB or uterovaginal prolapse. In particular, the
authors noted that 39% of patients who were referred for an
initial urogynecological assessment, including UDS, had
reported voiding difficulty. In the present study, the prev-
alence rates of mild and typical BOO were 10.5% and 1.6%
of the whole population (12.1% in total). Furthermore, we
should not only consider anatomic obstruction, but also
functional obstruction. Although several investigators
believe that UDS, which is an invasive and expensive test
(wUSD 500 in the USA in 2013 [20]), is not routinelywarranted [22], it is important to investigate the abnormal
characteristics in patients suffering from various types of
LUTS. CMG and PFS, along with simultaneous EMG, can help
identify IDO, ISO, DUA, SUI, or BOO. In addition to good
quality equipment and operator experience, patience and
awareness of the operator are also important to determine
these pathological results. Moreover, the potential for
surgical intervention among patients with an intact detru-
sor should also be considered, and it is essential to validate
their functional status in order to not only improve or
relieve their symptoms, but to cure them. Accordingly, a
balance should be maintained between reducing medical
expenses and ensuring necessary examination in these
patients.
To our knowledge, the definition of SUA is not clearly
provided in the literature. In the 2002 guideline of the ICS,
intrinsic sphincter deficiency has been referred to as
“urethral relaxation incontinence”, which should be vali-
dated by UPP [8], and is representative of SUA. Based on
CMG, PFS, and EMG findings, the presence of “uninhibited
sphincter relaxation” on EMG tracing during the storage
phase also indicates the presence of SUA. However, this
finding is rarely observed in patients with severe inconti-
nence and is never noted in patients with neurogenic le-
sions. At our institute, the definition of DUA and its
reversibility involves a 2-phase procedure, including UDS at
the initial consultation, followed by reexamination at 4e6
weeks after undergoing a strict DUA regimen. This method
of measurement and therapy is a novel non-standardized
approach, and it is considered that patients with DUA will
obtain useful results after undergoing this program [25,26].
ISO, which has also been termed as dysfunctional void-
ing, pseudodyssynergia, non-neurogenic neurogenic
bladder, Hinman syndrome, Fowler’s syndrome or learned
Figure 4 Urodynamic image data of three neurologically intact adult female patients with acute urinary retention and residual
urine volume of >2500 mL: (A) Case 1 includes a 49-year-old woman who presented with DUA4 at the first consultation; (B)
Following the application of the DUA regimen for 4 weeks, Case 1 showed voiding failure during follow-up, after which the catheter
was removed and fluent voiding was noted; (C) Flowmetry curve of Case 1 at 1 month after the CMG-PFS tests; (D) Case 2 includes a
33-year-old woman who presented with DUA4 at the first consultation; (E) After the DUA regimen was followed for 8 weeks, Case 2
showed disappearance of the DUA, recovery of micturition, and occasional IDO and ISO during the follow-up; (F) UPP test curves of
Case 2 at the first consultation; (G) Case 3 includes a 61-year-old woman who presented with DUA1 at the first consultation; (H)
After undergoing the DUA regimen for 5 weeks, Case 3 showed disappearance of the DUA, recovery of micturition, and occasional
ISO during the follow-up; (I) UPP test curves of Case 3 at the first consultation. DUA, detrusor underactivity; UPP, urethral pressure
profilometry.
UDS and LUTS in women with non-neurogenic bladder 17voiding dysfunction [5,27], is a type of non-neurogenic
LUTD involving the simultaneous contraction of the detru-
sor and sphincter during the voiding phase. It has been
described using a digitalization termdthe TL value [12]. In
the guidelines for children, dysfunctional voiding is
restricted to malfunction during the voiding phase only and
does not include the storage phase [28]. Hence, this
concept should be improved. In the present study, ISO or
IDO induced storage symptoms in 14.3% or 15.6% of pa-
tients, which appear to be higher than the rates for
storage þ voiding or voiding symptoms. Sacco and Bienti-
nesi described preliminary data supporting the rational for
using GABA analogs such as gabapentin and pregabalin in
neurogenic or non-neurogenic IDO [29]. Wang et al. [30]
indicated that the high prevalence of symptoms is not
equivalent to the severity of patient discomfort. Hence,
efforts should be made to improve public and professional
education, and further assessment of discomfort is required
before initiating a medical intervention. The pain caused by
BPS/IC is often obscure and is likely to be erroneously
identified as urgency in mild cases. Moreover, it is difficult
to distinguish such pain from OAB, vulvodynia, irritablebowel syndrome, endometriosis, and fibromyalgia [31].
However, these abnormalities may be related to functional
somatic syndrome [32]. Functional somatic syndrome may
be defined as “physical symptoms that cannot be explained
in terms of a conventionally defined disease, or appearing
in patients who do not have proportional tissue abnormal-
ities or pathologically defined changes in tissue that
designate medical conditions” [32]. Its symptoms cannot be
explained by organ pathology, and there are currently no
definitive diagnostic tests. Compared with PBS/IC, OAB is
more likely to represent a type of functional somatic syn-
drome. UDS can be used to explore the intrinsic mechanism
underlying the symptoms of pelvic pain, urgency, and other
lower urinary tract- and pelvic floor-associated disorders.
This study is a long-term clinical retrospective assess-
ment conducted in a single center. Although BOO and SUI
were considered, diagnosed, and stratified according to the
UDS patterns, the description of the therapy and follow-up
details were beyond the scope of the study and were hence
not included. Moreover, although video urodynamics was
not conducted and vesico-ureteral backflow, hydroureter,
or hydronephrosis were not identified, three types of
18 L. Wang et al.modern UDS systems were used during the 13-year period,
and the obstruction at the external sphincter level was
displayed as precisely as that on video UDS [3]. Moreover,
we observed the influence of psychological and emotional
factors on the function of the lower urinary tract; however,
this influence cannot be recorded in a very objective
manner considering the lack of appropriate methods. The
external urethral sphincter may be overactive, normal, or
underactive. In the guideline for neurogenic LUTD proposed
by the EAU, neurogenic LUTD was further categorized into
eight subgroups [4]; however, in our patients who were
neurologically intact, it was difficult to identify and define
SUA by using CMG, PFS, and EMG, and hence, this term is
avoided in the nomenclature of UDS patterns for adult fe-
male patients with LUTS (Fig. 1B).
5. Conclusion
We established a classification system for the urodynamic
patterns in patients with non-neurogenic LUTS based on a
modified version of the EUA-Madersbacher classification
system. Among the neurologically intact adult female pa-
tients with LUTS, we identified five UDS patterns, including
NA, IDO, IDO þ ISO, ISO, and DUA. The UDS data were found
to be very useful for the diagnosis and treatment of these
patients. The risk factors for BOO included NA, IDO, ISO,
and IDO þ ISO, whereas the protective factors against BOO
included storage symptoms, SUI, storage þ voiding symp-
toms, and complaint duration within 1e12 months. Only NA
was a risk factor for SUI, whereas the protective factors
against SUI were BOO, storage þ voiding symptoms, IDO,
and storage symptoms. Thus, UDS patterns provide more
information regarding the risk factors for BOO or SUI status
as compared to symptomatic typing.Conflicts of interest
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